Sihuan Pharmaceutical Unit Gets China Nod for Facial Filler

MT Newswires Live
03 Apr

China's medical products regulator granted Sihuan Pharmaceutical (HKG:0460) subsidiary Meiyan Space Biological Technology (Jilin) class 3 medical device approval for its injectable polycaprolactone microsphere facial filler.

The filler is a regenerative material that helps address facial contour deficiencies and corrects wrinkles in between the nose and lips, according to a Wednesday filing with the Hong Kong bourse.

Shares in the aesthetic product company fell 3% during afternoon trading on Thursday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10